Replies to post #781072 on NorthWest Biotherapeutics Inc (NWBO)

[JTORENCE]

"discussion took place in May or June 2025 on a brain cancer medicine"
And how do we know that it was NWBO's brain cancer medicine.?

[exwannabe]

The FOI reply is therefore not a casual acknowledgment that the MHRA possesses meeting summaries. It is a formal confirmation that they hold the exact information requested, that a CHM discussion took place in May or June 2025 on a brain cancer medicine, and that it will be made public in the CHM summary minutes when the formal publication process is complete.

May be it was discussed then, but the FOI reply does not establish that.

The question asked was :

I would greatly appreciate it if you could confirm whether any discussions during the most recent May 2025 or June 2025 CHM meetings involved a medicine for the treatment of brain cancer.

The meeting summary will answer Lykiri's question even if it was not discussed.

[manibiotech]

"The MAA was validated in March 2025"
Can you elaborate , which validation are you referring to ?Wasn't MAA submission validated in March 2024? Then how does this fit the timeline in regards to June CHM meeting under 150 day review path?

[hankmanhub]

and that it will be made public in the CHM summary minutes when the formal publication process is complete.

and how long should this "formal publication process" tale to complete, as they already have all this information ready to go?